Brazil's health regulators have approved Telix Pharmaceuticals' nuclear imaging agent for prostate cancer, Illucix.

A mum whose teenage son died after being diagnosed with bone cancer has called for more awareness of the disease's symptoms.

In a case report published in the World Journal of Oncology, an elderly female patient was diagnosed with mast cell leukemia (MCL), with imaging showing extensive osteoblastic metastatic lesions. MCL ...

DUOncoTM Bone : First CE marked IA algorithm for automatic detection of bone lesions on CT scan. DUOncoTM Bone : First CE ...

Telix’s Illuccix prostate cancer PSMA-PET imaging agent approved in the Netherlands: Melbourne, Australia Wednesday, March 19, 2025, 12:00 Hrs [IST] Telix, a biopharmaceutical c ...

His mother, Nicola Maxwell, said it took 14 months for Kieran to be sent for an X-ray after first seeing a doctor about pains. More than 150 youngsters in the UK are diagnosed with bone cancer ...

Metastatic breast cancer is complex, requiring holistic care and ongoing treatment, with varying prognosis depending on ...

The cancer risk from CT scans for any individual patient is very low, although it rises for patients who have numerous scans ...

A bone scan is a nuclear imaging test that can help tell you if you have certain types of bone disease. You may get this kind of scan to see if cancer has spread to your bones or to view how well ...

CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of the cancer experience.

Researchers warn that radiation from the machines can increase cancer risk. New Medicare rules aim to make these imaging ...

PSMA PET/CT trial will scan up to 1000 men in the UKA new kind of scan that could be key to improving the treatment of high-risk prostate cancer is ...